Phase
Condition
Amenorrhea
Treatment
N/AClinical Study ID
Ages 18-40 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Secondary amenorrhea of 3 or more consecutive months duration
Include the screening hormones (eg, estradiol (E2) < 50 pg/ml, Follicle-StimulatingHormone (FSH) <10 mIU/ml, and Luteinizing Hormone (LH) < 10mIU/ml and otherHA-defining hormones); or clinical diagnosis of HA by medical providers.
Pre-menopause status.
Able to give informed consent.
Exclusion
Exclusion Criteria:
A diagnosis for secondary amenorrhea including prolactinoma, Polycystic OvarySyndrome (PCOS), premature ovarian insufficiency, pituitary surgery, infection orinfarction
Pregnancy
Psychotropic/illicit drug use
Mental/neurological/major psychological disorders (other than depression andanxiety).
Parturition/lactating in the last 6-12 months.
Study Design
Connect with a study center
Mayo Clinic Florida
Jacksonville, Florida 32224
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.